| 0.488 Data as of May 17 |  +0.016 / +3.39%Today’s Change | 0.18 Today|||52-Week Range 2.00 | -53.08% Year-to-Date |
| Previous close | 0.47 |
| Today’s open | 0.48 |
| Day’s range | 0.47 - 0.50 |
| Volume | 66,490 |
| Average volume (3 months) | 230,441 |
| Market cap | $29.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +36.73% |
| Earnings growth (this year) | -26.88% |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | -98.86% |
| P/E ratio | NM |
| Price/Sales | 8,035.26 |
| Price/Book | 2.12 |
| Today’s change | Today’s % change | |
|---|---|---|
| MSTXMast Therapeutics In... | -0.01 | -1.06% |
| ADXSAdvaxis Inc | -0.00 | -2.94% |
| IDRAIdera Pharmaceutical... | +0.03 | +4.48% |
| CRMECardiome Pharma Corp | +0.03 | +1.42% |
| Next reporting date | August 16, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $5.1K |
| Annual profit (last year) | -$12.3M |
| Net profit margin | -240,906.58% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Patrick T. Mooney, MD |
Senior Vice President- Operations Marshall D. Deweese |
Corporate headquarters Philadelphia, Pennsylvania |
.
